1. Home
  2. NTNX vs NBIX Comparison

NTNX vs NBIX Comparison

Compare NTNX & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$71.63

Market Cap

18.3B

Sector

Technology

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$144.27

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
NBIX
Founded
2009
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3B
15.5B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
NTNX
NBIX
Price
$71.63
$144.27
Analyst Decision
Buy
Strong Buy
Analyst Count
16
29
Target Price
$77.79
★ $206.22
AVG Volume (30 Days)
★ 2.2M
1.2M
Earning Date
11-24-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 695.38
41.95
EPS
★ 5.17
3.30
Revenue
★ $2,853,545,000.00
$161,626,000.00
Revenue This Year
$12.76
$36.49
Revenue Next Year
$13.62
$16.87
P/E Ratio
★ $13.62
$43.24
Revenue Growth
12.44
★ 977.51
52 Week Low
$34.01
$122.14
52 Week High
$75.99
$186.12

Technical Indicators

Market Signals
Indicator
NTNX
NBIX
Relative Strength Index (RSI) 56.25 51.64
Support Level $65.94 $125.18
Resistance Level $75.21 $146.92
Average True Range (ATR) 2.31 3.11
MACD -0.27 1.09
Stochastic Oscillator 54.65 84.23

Price Performance

Historical Comparison
NTNX
NBIX

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: